Use of syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders

Details for Australian Patent Application No. 2007246779 (hide)

Owner New Era Biotech Ltd

Inventors Kaplan, Eliahu

Agent Shelston IP

Pub. Number AU-A-2007246779

PCT Pub. Number WO2007/129226

Priority 60/799,103 09.05.06 US

Filing date 9 May 2007

Wipo publication date 15 November 2007

International Classifications

A61K 31/00 (2006.01)

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

4 December 2008 PCT application entered the National Phase

  PCT publication WO2007/129226 Priority application(s): WO2007/129226

14 January 2010 Assignment before Grant

  New Era Biotech Ltd The application has been assigned to Novaremed Ltd

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007246782-Electric motor with a low number of revolutions, in particular to drive lifting devices

2007246776-Systems and methods for distributing emergency messages